170 related articles for article (PubMed ID: 3937942)
21. [Clinical effects of rifampicin for pulmonary tuberculosis patients. 2. Results of rifampicin treatment for advanced pulmonary tuberculosis patients resistant to conventional antituberculous drugs].
Kekkaku; 1971 Nov; 46(11):423-8. PubMed ID: 4335256
[No Abstract] [Full Text] [Related]
22. [Relations between resistance and virulence of mycobacteria].
Daddi G
Arch Monaldi; 1972; 27(4):426-35. PubMed ID: 4217599
[No Abstract] [Full Text] [Related]
23. Drug resistance of Mycobacterium tuberculosis strains isolated from patients with pulmonary tuberculosis in Archangels, Russia.
Toungoussova S; Caugant DA; Sandven P; Mariandyshev AO; Bjune G
Int J Tuberc Lung Dis; 2002 May; 6(5):406-14. PubMed ID: 12019916
[TBL] [Abstract][Full Text] [Related]
24. [Attributable factors to the emergence of multidrug-resistant Mycobacterium tuberculosis based on the observation of consecutive drug resistance test results].
Fujino T; Hasegawa N; Satou R; Komatsu H; Kawada K
Kekkaku; 1998 Jul; 73(7):471-6. PubMed ID: 9739579
[TBL] [Abstract][Full Text] [Related]
25. Experimental and clinical studies of rifampicin in tuberculosis.
Konno K; Oizumi K; Hayashi I; Oka S
Sci Rep Res Inst Tohoku Univ Med; 1970 Dec; 17(3):110-20. PubMed ID: 5004309
[No Abstract] [Full Text] [Related]
26. Rifampicin in the treatment of resistant pulmonary tuberculosis.
Wäre M; Lorenzen J
Scand J Respir Dis Suppl; 1970; 72():113-9. PubMed ID: 4990617
[No Abstract] [Full Text] [Related]
27. [Survival of tuberculous bacilli in combined treatments including rifampicin].
Kreis B; Pretet S
Rev Tuberc Pneumol (Paris); 1970; 34(3):429-33. PubMed ID: 4994940
[No Abstract] [Full Text] [Related]
28. Drug resistance to the first line of antitubercular regimen (a preliminary report).
Varaiya A; Gogate A
Indian J Public Health; 1998; 42(4):126-30. PubMed ID: 10389525
[TBL] [Abstract][Full Text] [Related]
29. [Clinical and bacteriological aspects of the drug resistance of Mycobacterium tuberculosis in patients with chronic destructive pulmonary tuberculosis].
Korotaev GA; Kozulitsyna TI; Tret'iakova EA; Mamed'iarova FA
Probl Tuberk; 1986; (7):32-6. PubMed ID: 3094001
[No Abstract] [Full Text] [Related]
30. [Study of rifampicin in the treatment of tuberculosis and nonspecific inflammatory lung diseases].
Rudoĭ NM; Zankisova IG; Eĭsaev BA
Antibiotiki; 1975 Oct; 20(10):945-8. PubMed ID: 813565
[TBL] [Abstract][Full Text] [Related]
31. [Efficacy of chemotherapy of pulmonary tuberculosis drug-resistant m.tuberculosis].
Khomenko AG; Chukanov VI; Korneev AA
Probl Tuberk; 1996; (6):42-4. PubMed ID: 9019768
[TBL] [Abstract][Full Text] [Related]
32. [Resistance of mycobacterial tuberculosis complex to the main antibacillary agent in Yaounde, Cameroon].
Bercion R; Kuaban C
Bull Soc Pathol Exot; 1998; 91(3):199-202. PubMed ID: 9773189
[TBL] [Abstract][Full Text] [Related]
33. Anti-tuberculosis drug resistance and HIV co-infection in Phnom Penh, Cambodia.
Sar B; Keo C; Leng C; Saman M; Min DC; Chan S; Monchy D; Sarthou JL
Southeast Asian J Trop Med Public Health; 2009 Jan; 40(1):104-7. PubMed ID: 19323041
[TBL] [Abstract][Full Text] [Related]
34. [Effectiveness of the rapid intravenous administration of rifampicin and isoniazid and of the intramuscular administration of streptomycin in disseminated destructive pulmonary tuberculosis in dogs].
Bondarev IM; Ivanov VL; Novoselova VP; Kovaleva LA; Shtegel'man LA
Antibiotiki; 1984 Jun; 29(6):430-4. PubMed ID: 6476805
[TBL] [Abstract][Full Text] [Related]
35. Drug resistant tuberculosis in Estonia.
Kruuner A; Sillastu H; Danilovitsh M; Levina K; Svenson SB; Källenius G; Hoffner SE
Int J Tuberc Lung Dis; 1998 Feb; 2(2):130-3. PubMed ID: 9562123
[TBL] [Abstract][Full Text] [Related]
36. [Activity of the second-line preparations, ethambutol and rifampin, in experimental tuberculosis caused by Mycobacterium tuberculosis highly resistant to basic tuberculostatics].
Golyshevskaia VI; El'shanskaia MP
Probl Tuberk; 1973; 51(12):60-4. PubMed ID: 4205666
[No Abstract] [Full Text] [Related]
37. [Clinical studies on the bacterial resistance to rifampicin].
Sakurai H; Inoue I; Yamagami K
Kekkaku; 1972 Dec; 47(12):475-9. PubMed ID: 4631478
[No Abstract] [Full Text] [Related]
38. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
Park SK; Kim JH; Kang H; Cho JS; Smego RA
Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
[TBL] [Abstract][Full Text] [Related]
39. Drug resistance in tuberculosis in Delhi: a 2 year profile (2001--2002).
Negi SS; Gupta S; Lal S
J Commun Dis; 2003 Jun; 35(2):74-81. PubMed ID: 15562952
[TBL] [Abstract][Full Text] [Related]
40. Outcome of chemotherapy in 107 patients with pulmonary tuberculosis resistant to isoniazid and rifampin.
Park SK; Kim CT; Song SD
Int J Tuberc Lung Dis; 1998 Nov; 2(11):877-84. PubMed ID: 9848607
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
